Corporate Announcement
Security Code : 507789    Company : JAGSNPHARM    
 
Jagsonpal Pharmaceuticals - Outcome of AGM 
  Exchange Disseminated Time     
Jagsonpal Pharmaceuticals Ltd has informed BSE that the members at the 28th Annual General Meeting (AGM) of the Company held on September 29, 2007, inter alia, have accorded the following:

1. Adoption of the Audited Balance Sheet as at March 31, 2007 and the Profit & Loss Account for the year ended on that date alongwith the Reports of the Auditors and Directors thereon.

2. Declared 2% Dividend on the Equity Shares.

3. Re-appointed of Mr. S Mukhopadhyay as Directors whose period of office is liable to determination by retirement of Directors by rotation.

4. Appointment of P P Thukral & Company, Chartered Accountants, as Auditor to hold office till the conclusion of the next Annual General Meeting.
 

Disclaimer

Back To Announcements